Bernard Motzko to become COO of Zumtobel Group in 2018

Bernard Motzko Bernard Motzko is to become the lighting group’s Chief Operating Officer (COO) in February 2018. Current COO Alfred Felder will be Management Board member responsible for luminaire sales. Together with CEO Ulrich Schumacher and CFO Karin Sonnenmoser, the new team is to focus on corporate development, reinforcing the Services sector and

University of Nottingham: cigarette butt-derived carbons have unprecedented hydrogen storage capacity

University of Nottingham: cigarette butt-derived carbons have unprecedented hydrogen storage capacity NOTTINGHAM, 01-Nov-2017 — /EuropaWire/ — Discarded cigarette butts are a major waste disposal and environmental pollution hazard. But chemists at the University of Nottingham have discovered that cigarette butt-derived carbons have ultra-high surface area and unprecedented hydrogen storage capacity. The research was

University of Nottingham and Nottingham City Council partnership sees more students contributing to their local community

University of Nottingham and Nottingham City Council partnership sees more students contributing to their local community NOTTINGHAM, 01-Nov-2017 — /EuropaWire/ — From roads and rail to Robin Hood energy, students and graduates are lending a fresh perspective to Nottingham’s public policy. The growth of a partnership with Nottingham City Council has seen more

University of Nottingham developed new early warning system to alert farmers to the risk of disease among their young cattle stock

University of Nottingham developed new early warning system to alert farmers to the risk of disease among their young cattle stock NOTTINGHAM, 01-Nov-2017 — /EuropaWire/ — A new early warning system to alert farmers to the risk of disease among their young cattle stock is being developed by experts at The University of Nottingham.

Sanofi: Phase 3 study on dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and key secondary endpoints

First study with a biologic to show benefit  in severe steroid-dependent asthma population that enrolled patients regardless of blood eosinophil levels or any other Type 2 biomarkers at baseline Pivotal program is first with a biologic to show consistent reductions in asthma attacks and improvements in lung function across a broad population of

Royal Philips showcases image-guided therapy portfolio at the Transcatheter Cardiovascular Therapeutics (TCT) annual event in Denver

Royal Philips showcases image-guided therapy portfolio at the Transcatheter Cardiovascular Therapeutics (TCT) annual event in Denver Philips’ image-guided therapy solutions is comprised of interventional X-ray and ultrasound systems, diagnostic and therapeutic devices, and clinical informatics and services designed to achieve improved patient outcomes and greater efficiency Amsterdam, the Netherlands and Denver, Colorado, 01-Nov-2017